AstraZeneca will pay $425 million to settle lawsuits on behalf of consumers who suffered kidney injuries while using its heartburn medications Nexium and Prilosec. AstraZeneca in a statement said ...

Oct. 3 (UPI) --Multinational pharmaceutical maker AstraZeneca said Tuesday it will pay $425 million to settle lawsuits from people who experienced kidney damage from the company's heartburn ...

Common medicines used to treat conditions including heartburn, reflux, indigestion and stomach ulcers may be the subject of a ...

An AstraZeneca Plc unit settled a federal patent-infringement lawsuit with a Samsung Biologics Co. subsidiary after failing to block its biosimilar version of the $500,000-per-patient drug Soliris.

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over ... GSK said in June that it had settled a lawsuit relating to Zantac – known chemically as ranitidine – and that ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

AstraZeneca unit and Samsung Bioepis resolve their patent dispute over a biosimilar | Settlement follows FDA approval for the ...

Purdue Pharma has agreed to pay $270 million to settle a lawsuit brought by Oklahoma ... interstitial cystitis and bladder pain syndrome. AstraZeneca has revealed the data for Imfinzi in muscle ...

Drugs giant AstraZeneca has agreed to settle a raft of legal claims over its heartburn ... GSK said in June that it had settled a lawsuit relating to Zantac – known chemically as ranitidine – and that ...